Losartan and enalapril are comparable in reducing proteinuria in children-Reference-Cited by-同舟云学术

Losartan and enalapril are comparable in reducing proteinuria in children

Published:2012-10 Issue:7 Volume:82 Page:819-826
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Webb Nicholas J.A.,Shahinfar Shahnaz,Wells Thomas G.,Massaad Rachid,Gleim Gilbert W.,Santoro Emanuela P.,Sisk Christine M.,Lam Chun

Publisher

Elsevier BV

Subject

Nephrology

Reference20 articles.

1. Prevalence of complications in children with chronic kidney disease according to KDOQI;Wong;Kidney Int,2006

2. Evaluation and Management of Proteinuria and Nephrotic Syndrome in Children: Recommendations From a Pediatric Nephrology Panel Established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE)

3. Understanding the nature of renal disease progression;Remuzzi;Kidney Int,1997

4. Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial;Grimm;Kidney Int Suppl,1997

5. Premature atherosclerosis (PA) in pediatric renal patients (PRP): report of the southwest pediatric nephrology study group (abstract);Portman;Pediatr Res,1991

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies;Trials;2024-03-21

2. Efficacy and safety of losartan in childhood immunoglobulin A nephropathy: a prospective multicenter study;Childhood Kidney Diseases;2023-12-07

3. Dual inhibition of the endothelin and angiotensin receptor ameliorates renal and inner ear pathologies in Alport mice;The Journal of Pathology;2023-05-31

4. Pediatric Chronic Kidney Disease;Advances in Pediatrics;2022-08

5. The Effect of Enalapril, Losartan, or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients;Oxidative Medicine and Cellular Longevity;2022-03-10